Hydromorphone (Dilaudid) Nursing Considerations

Hydromorphone, often recognized by its brand name Dilaudid, is a potent opioid agonist used to manage moderate to severe pain when other treatments fall short. But let’s be real, with its powerful effects come serious risks like respiratory depression, profound sedation, and a high potential for misuse—all highlighted in black box warnings. For a nurse, this isn’t just another medication; it’s a high-stakes balancing act where careful dosing and sharp monitoring directly impact patient safety.

Feeling a little nervous? You’ve got this. We’re here to break down this powerful medication into simple, digestible pieces. This guide will walk you through the essential nursing considerations for hydromorphone, so you can administer it with the confidence and skill of a seasoned pro.

Hydromorphone (Dilaudid) Drug Profile

• Generic Name: Hydromorphone hydrochloride
• Brand Names: Dilaudid, Exalgo
• Pharmacologic Class: Opioid analgesic, opioid receptor agonist (Schedule II)
• Mechanism of Action: Hydromorphone binds to opiate receptors in the central nervous system (CNS), altering the perception of and response to pain while causing generalized CNS depression. It also suppresses the cough reflex through a direct central action. For a quick refresher, check out our pharmacology guide.
• Therapeutic Uses: Its main purpose is the decrease in moderate to severe pain.

Hydromorphone (Dilaudid) Indications and Therapeutic Effects

Hydromorphone is indicated for:

• Primary Indications: Managing moderate to severe pain, used either alone or in combination with non-opioid analgesics. If you’re building a care plan, our Acute Pain Care Plan can help.
• Secondary Indications: Treating moderate to severe chronic pain in opioid-tolerant patients who require daily, around-the-clock, long-term opioid treatment.
• Adjunct Uses: It is often combined with non-opioid analgesics like acetaminophen or NSAIDs to provide a multimodal analgesia approach, which can help lower the required opioid dose.

Hydromorphone (Dilaudid) Dosage and Administration

Correct dosing is non-negotiable and depends on the patient’s pain level and tolerance.

• Adult Dosage (≥50 kg):
  • PO (Immediate-Release): 4–8 mg every 3–4 hours initially.
  • IV/IM/SUBQ: 1.5 mg every 3–4 hours as needed initially.
• Pediatric Dosage (<50 kg):
  • PO: 0.06 mg/kg every 3–4 hours initially (max dose 5 mg).
  • IV/IM/SUBQ: 0.015 mg/kg every 3–4 hours as needed initially.

Administration Tips

• Always assess a patient’s risk for opioid addiction, abuse, or misuse before administration.
• Do Not Crush (DNC): Extended-release tablets must be swallowed whole. Crushing, chewing, or dissolving them can cause an uncontrolled release, leading to overdose and death.
• IV Push: Administer slowly over 2–3 minutes. Rapid administration can lead to increased respiratory depression, hypotension, and circulatory collapse.
• Toxicity and Overdose: If an opioid antagonist is needed, naloxone (Narcan) is the antidote. The dose should be titrated carefully to reverse respiratory depression without triggering withdrawal or severe pain.
• Pediatric Safety: Medication errors with opioids are common in children. Always calculate doses carefully and use proper measuring devices.

Hydromorphone (Dilaudid) Pharmacokinetics

Here’s a quick look at how the body handles hydromorphone:

Hydromorphone (Dilaudid) Nursing Assessments

Your assessment is the cornerstone of safe opioid administration. You can find more assessment strategies in our Nursing Care Plans.

Baseline Evaluations

• Assess the type, location, and intensity of pain.
• Assess BP, heart rate, and respiratory rate before and periodically during administration.
• Assess the patient’s risk for opioid addiction, abuse, or misuse.

Ongoing Monitoring

• Reassess pain levels, respiratory rate, and sedation after initiation and with any dose changes.
• Monitor for hypotension and assess bowel function regularly.
• Frequently assess geriatric and pediatric patients, as they are more sensitive to opioid effects and may experience complications more often. For fall risks in older adults, our Risk for Falls care plan is a useful resource.

Hydromorphone (Dilaudid) Nursing Diagnoses

• Ineffective Breathing Pattern related to the CNS depressant effects of hydromorphone.
• Risk for Injury related to sedation and respiratory depression.
• Constipation (Risk/Actual) related to opioid therapy.
• Acute Pain related to tissue injury.
• Knowledge Deficit related to safe opioid use.

Hydromorphone (Dilaudid) Nursing Interventions & Patient Teaching

Your interventions focus on safe administration and empowering the patient with knowledge.

Patient Education

• Explain that this is for short-term relief of severe pain and must be taken exactly as prescribed. Do not share it.
• Teach them to immediately report trouble breathing, extreme sleepiness, confusion, severe dizziness, fainting, or signs of serotonin syndrome (agitation, sweating, tremors).

Lifestyle Modifications

• Advise them to avoid alcohol or other recreational sedatives.
• Warn them to avoid driving or other hazardous tasks until they know how the medication affects them.
• Strongly recommend a bowel regimen, including fiber, fluids, and stool softeners to prevent constipation. Get more tips from our Constipation Care Plan.

Medication Adherence & Monitoring

• Take immediate-release formulas exactly as directed. If a dose is missed and it’s almost time for the next one, skip it. Never double the dose.
• Swallow extended-release tablets whole.
• Avoid alcohol, and maintain hydration and fiber to prevent constipation.

Hydromorphone (Dilaudid) Adverse Effects and Management

• Common Side Effects: Lightheadedness, dizziness, sedation, nausea/vomiting, and constipation. Manage these with antiemetics, safety precautions, and a bowel regimen.
• Serious Adverse Effects:
  • Respiratory depression/apnea: This is the big one.
  • Profound sedation/coma: Higher risk when mixed with benzodiazepines or alcohol.
  • Severe hypotension: Monitor BP closely. Our hypotension care plan can help guide your interventions.
  • Serotonin Syndrome: Can occur when taken with other serotonergic drugs.
  • Neonatal Opioid Withdrawal: Can occur with prolonged use during pregnancy.

Management Strategies

• Hold the dose and notify the provider for a respiratory rate below 12/min, escalating sedation, or a significant drop in blood pressure.
• Consider naloxone for a suspected overdose, following your facility’s protocol.
• Taper the dose for physically dependent patients rather than stopping abruptly.

Hydromorphone (Dilaudid) Contraindications and Cautions

• Contraindications: Do not use with hypersensitivity, severe respiratory depression, acute or severe bronchial asthma, or paralytic ileus.
• Cautions:
  • Use with extreme caution in patients with head trauma or increased intracranial pressure.
  • Dose reductions are recommended for patients with moderate-to-severe renal or hepatic impairment. See our Chronic Kidney Disease or Liver Cirrhosis care plans for more.
  • Older adults may have an increased risk of respiratory depression; a lower dose is suggested.

Hydromorphone (Dilaudid) Drug Interactions

• BLACK BOX WARNING: Use with benzodiazepines or other CNS depressants (including other opioids and alcohol) may cause profound sedation, respiratory depression, coma, and death. Reserve concurrent use for when alternative options are inadequate.
• MAO Inhibitors: Can produce severe, unpredictable reactions. Discontinue MAOIs 2 weeks prior to starting hydromorphone.
• Serotonergic Drugs: Use with SSRIs, SNRIs, and other similar drugs increases the risk of serotonin syndrome.

For a quick reference on drug classes and interactions, check out our 150 Drug Card resource.

Hydromorphone (Dilaudid) Evaluation and Desired Outcomes

• Pain Relief: The primary goal is a decrease in the severity of pain without a significant alteration in the patient’s level of consciousness or respiratory status.

References for Hydromorphone (Dilaudid) Drug Guide

• Vallerand, A. H. & Sanoski, C. A. (2025). Davis’s Drug Guide for Nurses. In Davis’s Drug Guide (19th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/51000/all/